Patents Assigned to Andida Pharma, Inc.
  • Methods of treating ototoxicity
    Patent number: 9468620
    Abstract: The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ototoxicity, by administering these compounds or pharmaceutical compositions to subjects in need thereof. Ototoxicity is defined as damage to the structures of the ear, such as the cochlea and vestibular system, by drugs or toxins. Ototoxicity can result in irreversible hearing loss, tinnitus, dysequilibrium, Meniere's disease, or vertigo.
    Type: Grant
    Filed: February 26, 2014
    Date of Patent: October 18, 2016
    Assignee: Andida Pharma, Inc.
    Inventor: Per Gjorstrup